Loading quotes...
Core data
| Name | Kelly CRISPR & Gene Editing Technology ETF |
| Issuer | iShares |
| Fund domicile | Canada |
| TER | 0.52% |
| Fund size | €11.55m |
| P/E ratio | 17.46 |
| P/B ratio | 3.67 |
| Inception date | 26/04/2022 |
| Website |
Composition
| Holdings | Share |
|---|---|
| 11.24% | |
| 7.66% | |
| 4.89% | |
| 3.99% | |
| 3.89% | |
| 3.45% | |
| 3.36% | |
| 3.35% | |
| 3.26% | |
| 3.23% |
As of 01/10/2026
Top sectors
| Sector | Share |
|---|---|
Health Care | 94.10% |
Materials | 1.10% |
Top countries
| Country | Share |
|---|---|
USA | 63.77% |
France | 8.28% |
Japan | 6.05% |
Switzerland | 5.95% |
Germany | 4.79% |
United Kingdom | 3.79% |
Denmark | 3.65% |
China | 2.08% |
Canada | 1.04% |
South Korea | 0.60% |
